Allostem

Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone AlloGraft

Centennial, Colo. — July 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that Dr. Nicole Ehrhart, Professor of Surgical Oncology at the Colorado State University (CSU) Flint Animal Cancer Center, presented preclinical data on adiposederived mesenchymal stem cells at the State of Spine Surgery 13th Annual Symposium and will present at the Korean American Spine Society meeting on July 9, 2016. Dr. Ehrhart’s preclinical study, entitled Adipose-Derived Mesenchymal Stromal Cells Seeded on Demineralized Bone Matrix Persist…